138 related articles for article (PubMed ID: 33615627)
1. Trophoblast cell surface antigen 2 expression predicts outcome in oral squamous cell carcinomas.
Dourado MR; Machado RA; Paranaíba LMR; González-Arriagada WA; da Silva SD; Sawazaki-Calone Í; Graner E; Salo T; Coletta RD
Oral Dis; 2022 May; 28(4):1085-1093. PubMed ID: 33615627
[TBL] [Abstract][Full Text] [Related]
2. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
3. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
[TBL] [Abstract][Full Text] [Related]
4. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.
Fong D; Spizzo G; Gostner JM; Gastl G; Moser P; Krammel C; Gerhard S; Rasse M; Laimer K
Mod Pathol; 2008 Feb; 21(2):186-91. PubMed ID: 18084248
[TBL] [Abstract][Full Text] [Related]
5. TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway.
Tang G; Tang Q; Jia L; Chen Y; Lin L; Kuai X; Gong A; Feng Z
Int J Mol Med; 2019 Dec; 44(6):2161-2170. PubMed ID: 31638186
[TBL] [Abstract][Full Text] [Related]
6. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma.
Wu H; Xu H; Zhang S; Wang X; Zhu H; Zhang H; Zhu J; Huang J
Head Neck; 2013 Oct; 35(10):1373-8. PubMed ID: 22987366
[TBL] [Abstract][Full Text] [Related]
7. [Effect of human trophoblast cell-surface antigen 2 gene expression by RNA interference on proliferation and apoptosis of tongue squamous cell carcinoma and its mechanism].
Fang Z; Chen S; Zhao JF; Sun Q; Qiu F; Li XM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Sep; 53(9):640-644. PubMed ID: 30196628
[No Abstract] [Full Text] [Related]
8. Trop2 inhibition of P16 expression and the cell cycle promotes intracellular calcium release in OSCC.
Jia L; Wang T; Ding G; Kuai X; Wang X; Wang B; Zhao W; Zhao Y
Int J Biol Macromol; 2020 Dec; 164():2409-2417. PubMed ID: 32768481
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
11. Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma.
Erber R; Spoerl S; Mamilos A; Krupar R; Hartmann A; Ruebner M; Taxis J; Wittenberg M; Reichert TE; Spanier G; Spoerl S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008509
[TBL] [Abstract][Full Text] [Related]
12. Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis.
Zeng P; Chen MB; Zhou LN; Tang M; Liu CY; Lu PH
Sci Rep; 2016 Sep; 6():33658. PubMed ID: 27645103
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
14. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
Spoerl S; Gerken M; Mamilos A; Fischer R; Wolf S; Nieberle F; Klingelhöffer C; Meier JK; Spoerl S; Ettl T; Reichert TE; Spanier G
Clin Oral Investig; 2021 Apr; 25(4):1705-1713. PubMed ID: 32754787
[TBL] [Abstract][Full Text] [Related]
15. TROP2 expression as prognostic marker for gastric carcinoma.
Mühlmann G; Spizzo G; Gostner J; Zitt M; Maier H; Moser P; Gastl G; Zitt M; Müller HM; Margreiter R; Ofner D; Fong D
J Clin Pathol; 2009 Feb; 62(2):152-8. PubMed ID: 18930986
[TBL] [Abstract][Full Text] [Related]
16. Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma.
Arun I; Maity N; Hameed S; Jain PV; Manikantan K; Sharan R; Arun P
Head Neck; 2021 Feb; 43(2):520-533. PubMed ID: 33021340
[TBL] [Abstract][Full Text] [Related]
17. Associations between RORγt and T-bet Expressions, clinicopathological indices and survival rate in oral Squamous cell carcinoma patients.
Ghelichli M; Mohtasham N; Mohajertehran F; Farshbaf A; Anvari K; Taghipour A; Pakfetrat A; Ansari AH
Cytokine; 2023 Mar; 163():156116. PubMed ID: 36621309
[TBL] [Abstract][Full Text] [Related]
18. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
Bu J; Bu X; Liu B; Chen F; Chen P
Med Sci Monit; 2015 Aug; 21():2275-81. PubMed ID: 26242444
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of FOXD1 is associated with cervical node metastasis and unfavorable prognosis in oral squamous cell carcinoma.
Li Z; Yan T; Wu X; Zhang W; Li J; Wang L; Yang J
J Oral Pathol Med; 2020 Nov; 49(10):1030-1036. PubMed ID: 32808339
[TBL] [Abstract][Full Text] [Related]
20. PAI-1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma.
Peterle GT; Maia LL; Trivilin LO; de Oliveira MM; Dos Santos JG; Mendes SO; Stur E; Agostini LP; Rocha LA; Moysés RA; Cury PM; Nunes FD; Louro ID; Dos Santos M; da Silva AMÁ
J Oral Pathol Med; 2018 Jul; 47(6):566-574. PubMed ID: 29693741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
